Reid Fursmidt

In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment

Matthew J. O’Meara, C. Wobus, C. Mirabelli, 2022, Vaccines.

In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment

Matthew J. O’Meara, C. Wobus, C. Mirabelli, 2022, bioRxiv.

Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern

J. Sexton, L. Ward, J. W. Wotring, 2022, Journal of Dairy Science.

Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19

Matthew J. O’Meara, G. Mashour, A. Chinnaiyan, 2021, Proceedings of the National Academy of Sciences.

Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19

Matthew J. O’Meara, G. Mashour, Tristan Frum, 2020, bioRxiv.